Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 2/20 | 0.33 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.31 |
| ▸ | PYGB | P11216 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16687520 | 0.91 | LGALS3 (0.39) | LGALS8LGALS3PYGB | |
| SCHEMBL13199410 | 0.90 | OGA (0.33) | LGALS8PYGB | |
| SCHEMBL14270421 | 0.86 | — | — | |
| SCHEMBL13598327 | 0.84 | LGALS3 (0.31) | LGALS3PYGB | |
| SCHEMBL13827606 | 0.84 | LGALS3 (0.33) | LGALS3PYGB | |
| SCHEMBL13820244 | 0.84 | LGALS3 (0.33) | LGALS3PYGB | |
| SCHEMBL19823488 | 0.82 | MAPK1 (0.33) | — | |
| SCHEMBL16187163 | 0.81 | CA2 (0.32) | — | |
| SCHEMBL19085442 | 0.81 | MAPK1 (0.32) | — | |
| SCHEMBL12873387 | 0.79 | CA2 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11793752-B2 | Aqueous gel composition and its use | UNIVERSITY OF COPENHAGEN (DK) | 2023-10-24 | — | — | US | disclosed |
| US-20180028558-A1 | THERAPEUTIC POLYSACCHARIDE MIDI-GAGR AND RELATED MATERIALS AND METHODS | THE UNIVERSITY OF TOLEDO (US) | 2018-02-01 | — | — | US | disclosed |
| US-20170189333-A1 | Aqueous gel composition and its use | UNIVERSITY OF COPENHAGEN (DK) | 2017-07-06 | — | — | US | disclosed |
| US-20160136232-A1 | TUNABLE ANTI-MICROBIAL LOADED HYDROGELS | BROWN UNIVERSITY | 2016-05-19 | — | — | US | disclosed |
| US-8383154-B2 | Swellable dosage form comprising gellan gum | EGALET A/S (DK) | 2013-02-26 | — | — | US | disclosed |
| US-8383155-B2 | Swellable dosage form comprising gellan gum | EGALET A/S (DK) | 2013-02-26 | — | — | US | disclosed |
| US-20120039969-A1 | SWELLABLE DOSAGE FORM COMPRISING GELLAN GUM | EGALET A/S | 2012-02-16 | — | — | US | disclosed |
| US-20080299199-A1 | Swellable Dosage Form Comprising Gellan Gum | EGALET A/S | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120039969-A1 | SWELLABLE DOSAGE FORM COMPRISING GELLAN GUM | PUF60, COG6, GP6 | LGALS8 1900/4885LGALS3 242/4885PYGB 783/4885 |
| US-20160136232-A1 | TUNABLE ANTI-MICROBIAL LOADED HYDROGELS | CUTA, HSP90AA1, HSF1 | LGALS8 462/4885LGALS3 56/4885PYGB 3228/4885 |
| US-20180028558-A1 | THERAPEUTIC POLYSACCHARIDE MIDI-GAGR AND RELATED MATERIALS AND METHODS | ALG1, GLA, ENGASE | LGALS8 281/4885LGALS3 170/4885PYGB 114/4885 |
| US-20170189333-A1 | Aqueous gel composition and its use | TAS2R40, CD44, TAS2R50 | LGALS8 240/4885LGALS3 347/4885PYGB 458/4885 |
| US-11793752-B2 | Aqueous gel composition and its use | TAS2R40, CD44, TAS2R50 | LGALS8 240/4885LGALS3 347/4885PYGB 458/4885 |
| US-20080299199-A1 | Swellable Dosage Form Comprising Gellan Gum | GP6, PUF60, SELL | LGALS8 2217/4885LGALS3 303/4885PYGB 711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.